US Capital Global Holds Successful San Francisco Event Entitled “Lessons Learned from Theranos”
San Francisco-based private financial group hosts lively event exploring the fall of health technology company Theranos and how it could have been prevented.
SAN FRANCISCO, MAY 2018 – On May 3rd, US Capital Global hosted a well-attended, open event exploring the downfall of Theranos, the highly valued, “revolutionary” blood-testing company charged with securities fraud by the U.S. Securities and Exchange Commission. Entitled “Lessons Learned from Theranos” and co-hosted by New Finance, the event was held at Squire Patton Boggs’ San Francisco headquarters.
Headquartered in San Francisco, US Capital Global is a full-service private financial group with a strong focus on RegTech and capital raise services. The firm aims to provide lower middle market businesses and investors with sophisticated debt, equity, and investment opportunities usually available only to larger companies and institutional investors.
The San Francisco event engaged individuals from across investment banking and the legal sector in a lively discussion on the importance of appropriate professional advice when raising capital. It follows the publication of an article on the Theranos fraud settlement by Chairman and CEO Jeffrey Sweeneyin The Fintech Times.
Establishing where Theranos and Elizabeth Holmes had gone wrong, the discussion emphasized the unique skills and experience of licensed investment banking professionals to perform thorough due diligence and to structure a raise where the responsibilities and risks are held by those equipped to manage them. Not only do banking professionals serve to protect issuers from inadvertent misrepresentations and the subsequent consequences, but they serve to protect investors as well, allowing them to trust the information they receive.
Dr. James Baty, Ph.D., a partner at US Capital Global and a recognized expert in the FinTech arena, spoke at the event alongside Frank Placenti, who serves as chair at Squire Patton Boggs’ US Corporate Governance and Securities Regulation Practice and is known for his experience in stock exchange investigatory matters.
Mr. Sweeney, who led the event, commented: “It’s very exciting to hold engaging events such as these where those with a diversity of experience and knowledge are able to come together to help protect and support the future of investors and issuers alike. The work we do is aimed at creating a clear and solid platform for the growth of companies and those who support them with their investments, and we are certain that Theranos could have avoided its financial and career-ending disaster if it had entrusted licensed investment bankers with the sale of its securities.”
US Capital Global is committed to giving back to the local community. All proceeds from this San Francisco event were donated to the SF-Marin Food Bank.
About US Capital Global
Since 1998, the US Capital team has been committed to providing small and lower middle market businesses and investors with sophisticated debt, equity, and investment opportunities usually available only to larger middle market companies and institutional investors. The US Capital Global group manages direct investment funds and provides wealth management and capital raise services. Operating with its registered investment bank affiliate, US Capital Global Securities, LLC, the firm acts as a licensed placement agent for companies, funds, and projects, and collaborates closely with its peers in professional banking and investment advisory. www.uscapglobal.com
To learn more about how your business can secure the funding it needs, email Jeffrey Sweeney, Chairman and CEO, at jsweeney@uscapglobal.comor call (415) 889-1010
